COPENHAGEN, Denmark, Aug. 07, 2025 (GLOBE NEWSWIRE) — SNIPR Biome ApS (“SNIPR”), the company pioneering the development of microbial CRISPR-medicine, today announced the close of a EUR 35 million Series B raise with funding from…Read More

You might also be interested in reading Golden run spells trouble as more investors seek a safe haven from turbulent financial markets: MAGGIE PAGANO.